Search

Steven Degon Phones & Addresses

  • 205 Gray St, North Andover, MA 01845
  • 234 Old Billerica Rd, Bedford, MA 01730 (781) 275-1842
  • 1 Mcnamara Way, Burlington, MA 01803
  • 1 Mcnamara Way #26, Burlington, MA 01803
  • 9 Carlson Rd, Hampton, NH 03842
  • N Billerica, MA
  • Augusta, ME
  • 234 Old Billerica Rd, Bedford, MA 01730

Publications

Us Patents

Web Handling With Tension Sensing And Adjustment

View page
US Patent:
7118062, Oct 10, 2006
Filed:
Jul 31, 2003
Appl. No.:
10/632237
Inventors:
Nandakumar Vaidyanathan - Litchfield NH, US
Steven Degon - Northboro MA, US
Robert Bruce Lowd - Chestnut Hill MA, US
Brian Roland Lamoureux - Pelham NH, US
Keith Vaillancourt - Pelham NH, US
James Hand - Pelham NH, US
Assignee:
Presstek, Inc. - Hudson NH
International Classification:
B65H 23/18
US Classification:
2424121, 2424122, 2424135, 2424181, 2424206, 2425382, 226 45, 700122
Abstract:
A system of detecting and adjusting the normal force exerted by a web material around the circumferential surface of a cylinder is provided. Sensors associated with the cylinder surface are wired to a processor that compares detected normal web forces with a set value. An actuation device is activated by the processor to adjust the normal force exerted by the web by, e. g. , adjusting the tension in the web material. A positioning device that preferably translates a web-wound spool is also provided as an option for the actuation device.

Stabilization Of Fc-Interferon-Beta Fusion Proteins

View page
US Patent:
8557232, Oct 15, 2013
Filed:
Feb 27, 2009
Appl. No.:
12/395165
Inventors:
Stephen D. Gillies - Carlisle MA, US
Nigel John Watkins - Cambridgeshire, GB
Matthew Paul Baker - Cambridge, GB
Kin-Ming Lo - Lexington MA, US
Steven C. Degon - Hampton NH, US
Assignee:
Merck Patent GmbH - Darmstadt
International Classification:
A61K 38/21
A61K 38/00
A61K 39/00
C07K 14/565
US Classification:
424 856, 4241341, 514 11, 530351
Abstract:
Disclosed are Fc-interferon-beta (Fc-IFN-β) fusion proteins and nucleic acid molecules encoding them. The Fc-IFN-β fusion proteins include variants of the interferon-beta (IFN-β) protein that are altered to achieve enhanced biological activity, prolonged circulating half-life and greater solubility. Also disclosed are methods of producing the fusion proteins and methods of using the fusion proteins and/or nucleic acid molecules for treating diseases and conditions alleviated by the administration of interferon-beta.

Web Handling Cylinder With Modulated Tension Loss

View page
US Patent:
20040025726, Feb 12, 2004
Filed:
Jul 31, 2003
Appl. No.:
10/632238
Inventors:
Nandakumar Vaidyanathan - Litchfield NH, US
Steven Degon - Northboro MA, US
Robert Lowd - Chestnut Hill MA, US
Brian Lamoureux - Pelham NH, US
Keith Vaillancourt - Pelham NH, US
James Hand - Pelham NH, US
Assignee:
Presstek, Inc. - Hudson NH
International Classification:
B41F013/54
US Classification:
101/228000
Abstract:
Systems and related methods are provided for modulating web tension loss at the edge of spool-hosting cavities in a cylinder by displacing the feed path and/or the exit path of the web material.

Assembly And Folding Of Fc-Interferon-Beta Fusion Proteins

View page
US Patent:
20060228332, Oct 12, 2006
Filed:
Jun 27, 2005
Appl. No.:
11/167767
Inventors:
Stephen Gillies - Carlisle MA, US
Nigel Watkins - Cambridge, GB
Matthew Baker - Cambridge, GB
Kin-Ming Lo - Lexington MA, US
Steven Degon - Hampton NH, US
Assignee:
MERCK Patent GmbH - Darmstadt
International Classification:
A61K 38/21
C07H 21/04
C12P 21/04
C07K 14/565
C07K 16/46
US Classification:
424085600, 435069510, 435320100, 435325000, 530351000, 530391100, 536023500
Abstract:
Disclosed are Fc-interferon-beta (Fc-IFN-β) fusion proteins and nucleic acid molecules encoding them. The Fc-IFN-β fusion proteins include variants of the interferon-beta (IFN-β) protein that are altered to achieve enhanced biological activity, prolonged circulating half-life and greater solubility. Also disclosed are methods of producing the fusion proteins and methods of using the fusion proteins and/or nucleic acid molecules for treating diseases and conditions alleviated by the administration of interferon-beta.

Fc-Interferon-Beta Fusion Proteins

View page
US Patent:
20140005361, Jan 2, 2014
Filed:
Aug 26, 2013
Appl. No.:
14/010072
Inventors:
- Darmstadt, DE
Nigel John Watkins - Cambridge, GB
Matthew Paul Baker - Cambridge, GB
Kin-Ming Lo - Lexington MA, US
Steven C. Degon - Hampton NH, US
Assignee:
MERCK PATENT GMBH - Darmstadt
International Classification:
C07K 14/565
C07K 16/46
US Classification:
530351
Abstract:
Disclosed are Fc-interferon-beta (Fc-IFN-β) fusion proteins and nucleic acid molecules encoding them. The Fc-IFN-β fusion proteins include variants of the interferon-beta (IFN-β) protein that are altered to achieve enhanced biological activity, prolonged circulating half-life and greater solubility. Also disclosed are methods of producing the fusion proteins and methods of using the fusion proteins and/or nucleic acid molecules for treating diseases and conditions alleviated by the administration of interferon-beta.
Steven C Degon from North Andover, MA, age ~68 Get Report